Author

S. Heijhuurs

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

J. Kuball· 2 shared Z. Sebestyen· 2 shared A. D. Meringa· 1 shared A. Slomp· 1 shared D. M. Bosma· 1 shared D. Rockx-Brouwer· 1 shared D. X. Beringer· 1 shared E. van Diest· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. Kuball

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Engineering BCMA CAR T cells for myeloma-targeted cargo delivery

T. Kimman, M. Cuenca, A. Slomp, R. G. Tieland, D. Rockx-Brouwer, S. Heijhuurs, A. D. Meringa, W. Boschloo, D. M. Bosma, S. Kroos, V. lo Presti, S. Nierkens, N. Bovenschen, J. Kuball, M. C. Minnema, , V. Peperzak

This paper develops BCMA CAR T cells with a granzyme B-NOXA fusion to enhance apoptosis in multiple myeloma cells, improving killing efficacy in vitro and in xenograft models.

bioRxiv · Feb 14, 2024 · PreprintImmunology

Enhancing cancer targeting of γ9δ2TCR through modified NKG2D co-stimulation

P. Hernandez-Lopez, E. van Diest, I. Johanna, S. Heijhuurs, T. Straetemans, Z. Sebestyen, D. X. Beringer, J. Kuball

This paper improves the antitumor activity of TEG001 by co-expressing NKG2D-based chimeric co-receptors with the {gamma}{delta}TCR-Cl5.

bioRxiv · Jan 6, 2021 · PreprintImmunology